Mandy East Professional’s Conference November 10th 2016

Slides:



Advertisements
Similar presentations
Clinical Audit on: The Clinical Guidelines for Prescription of Epinephrine Auto Injectors (Epipen, Anapen) for Food Allergy in The Paediatric Allergy Clinic.
Advertisements

Revalidation for nurses and midwives consultation phase 2
Revalidation and Code review update November 2014.
Transfer Review Briefings
Voluntary Guidelines for Managing Food Allergies in Schools and Early Care and Education Programs.
Benefits for using a standardised risk management framework to risk assess Infection Prevention and Control Sue Greig Senior Project Officer National.
Anaphylaxis: Life Threatening Allergic Reactions School Staff Training
Life Threatening Food Allergies in Schools and Educational Programs Why We Need State Mandated Guidelines Suzette Cyr, RN, BSN Jennifer Kelley, RN BSN.
The 0-25 Special Educational Needs and Disability (SEND) Reforms (Children and Families Act 2014) School Governor Briefing September 23 rd 2014 Liz Malcolm.
GUIDELINES FOR MANAGEMENT OF ANAPHYLAXIS IN EDUCATIONAL ESTABLISHMENTS DHSSPS /DOE 2010.
Guildford and Waverley CCG Medicines Management - update on adrenaline autoinjectors 24 th July 2014.
1 Anaphylaxis training course Providing up-to-date information about managing severe allergies in schools.
Managing Severe Allergies within Schools. What is Anaphylaxis? Anaphylaxis is a severe systemic allergic reaction. At the extreme end of the allergic.
Getting it right for e ery child  Children & Young People (Scotland) Act 2014 Briefing on GIRFEC Provisions Lynn Townsend.
How to use the EFQM Excellence Model to empower patients and staff create a latex- safe environment Karen Cunningham Health & Safety Manager Musgrave Park.
Allergy in 10 minutes DETECTIVE WORK Presenting episode Previous episodes Consistent trigger or pattern to episodes Contacts/Foods in previous 4 hours.
2014/15.  The Joint Project Board has published the arrangements for the joint teaching of the PCMD cohort of students.  This aims to safeguard the.
GUIDELINES FOR MANAGEMENT OF ANAPHYLAXIS IN EDUCATIONAL ESTABLISHMENTS DHSSPS /DOE 2010 Revised October 2015.
SpringwellSchool Hinkler Road, Thornhill, Southampton, SO19 6DH Supporting pupils at school with medical conditions.
Brief Update 0-19 Prevention Service
Transfer Reviews September 2016 – March 2018 February 2016.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
The Aarhus Convention Reporting Mechanism National Implementation Reports 2011 Experience and lessons learned Aphrodite Smagadi, Aarhus Convention secretariat.
HSC 3047 :Part 3 Support the use of medication in social care settings: Adverse drug reaction Sheena Helyer Pictures provided by cadista.com.
Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw Published March 2017.
Partnership in Action – Keeping Children Safer
Use MY data use MY data is a movement for patients; it aims to build confidence in the use of patient data for analysis and research. Timely access to.
Anaphylaxis Tariq El-Shanawany, University Hospital of Wales, UK
Off-label Use.
3-MINUTE READ WORKING TOGETHER TO SAFEGUARD CHILDREN.
ACIP Recommendations Update for the U.S. Influenza Season
Allergy and Anaphylaxis in the School Setting
Disclosure UK Talking about Transparency.
Access to Epinephrine for Self-Administration (EPI Rph)
PHARMACIST : A HEALTH CARE PROFESSIONAL
Appropriate use and potential side effects of TCS
A Single Centre Experience In Managing Anaphylaxis In The Emergency Department Iman Nasr1; Joanna Lukawska1,2; Runa Ali1; Ikram Nasr3; Jason Pott1; Tim.
NAP6 Perioperative Anaphylaxis
Risk Communication in Medicines
Results from a survey of UK patients at risk of bowel cancer, their experiences and information preferences. Selina Goodman, Heather Skirton, Ray Jones.
3-MINUTE READ WORKING TOGETHER TO SAFEGUARD CHILDREN.
Definition of School Nursing
Influenza Information Needs of Primary Care Physicians
Anaphylaxis Management Briefing
Disclosure UK Talking about Transparency.
Health Update Elly Wright Complex needs team leader 0-19 service.
Medication use in care homes
All Wales Safeguarding Procedures Review Project
2018 Sedgwick Science Camp Forms:
End of Year Performance Review Meetings and objective setting for 2018/19 This briefing pack is designed to be used by line managers to brief their teams.
68.3 million errors (28% of total) cause moderate or serious harm
Antibiotics Shuaib Nasser Cambridge University Hospitals NHS Foundation Trust NAP6 Steering Committee member.
Information for Patients Please return to reception
Workshop: SDS & Social Work – Making it work
FOOD ALLERGY ITALIA In Europe, food allergy affects 4-7% of children attending Primary School. (Muraro et al., Allergy, 2010) The life-time prevalence.
Presentation Title 36pt Arial Bold
Division 4 Medical Emergencies
Compliance With NICE Guidelines for Children At Risk of Anaphylaxis In a Tertiary Allergy Centre Thaventhiran, P and Benjamin, L Children’s Allergy Service.
Principal recommendations
NAP6 – the independent/private sector m Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
Prabalini Thaventhiran Deputy Clinical Nurse Specialist
Social prescribing: Less rhetoric and more reality
Medicines Safety Programme
Dry Eyes – Lubricant Eye Drops
Children & Young People (Scotland) Act 2014 Briefing on GIRFEC Provisions Lynn Townsend Education /Implementation Lead Scottish Government GIRFEC Team.
Contact: Anuradha Bhatt, MPH
Allergies and Anaphylaxis awareness for Schools & Early Years settings
The process of secondary school transfer for pupils with an EHC Plan is different to those children who don’t have an EHC Plan. Children who have an EHC.
Presentation transcript:

Mandy East Professional’s Conference November 10th 2016 Campaign to introduce Spare Adrenaline Auto Injectors (AAIs) into educational establishments in the UK Mandy East Professional’s Conference November 10th 2016

NICE Definition Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction. Characterised by rapidly developing, life-threatening problems involving: the airway (pharyngeal or laryngeal oedema) and/or breathing (bronchospasm with tachypnoea) and/or circulation (hypotension and/or tachycardia).

Is there a problem? Up to 6% of school-aged children have IgE-mediated food allergy 1 anaphylaxis episode per 10,000 children p.a. 82% of food anaphylaxis occurs in school-age children 61% of schools have at least 1 child with prior anaphylaxis / AAI prescription Bohlke et al. JACI 2004;113:536–542 Nwaru et al. Allergy 2014;69:62-75.

Anaphylaxis Anaphylaxis cannot be predicted Most fatalities occur in people with previous mild reactions Many children with prior anaphylaxis have mild reactions in the future Fatal anaphylaxis is rare but unpredictable 17% of fatal reactions occur in schools / preschool settings Adrenaline auto-injectors commonly prescribed as rescue medication to treat anaphylaxis

Adrenaline auto-injector devices Data: NHS Prescription Cost Analysis for England, 2000-2012

AAI devices Most children respond to one AAI but some may require a further dose device may misfire due to user error or malfunction Most children with AAI therefore prescribed 2 devices, consistent with MHRA and EMA guidance Children and Families Act (2014) requires schools to make arrangements for supporting children with medical conditions individual care plan

UK National Survey April to June 2015

Methodology Bespoke online survey Parents, HCPs and teachers were invited to complete the survey using patient group databases and social media Surveys open for completion for 8 weeks from April 27th 2015

Results Responses were received from: 1609 parents 519 healthcare professionals 821 teachers

Research questions How common are AAIs in schools? Are there situations where the AAI may not be correctly administered to children? e.g. Lack of availability, misfiring or device out of date? Is there support for the introduction of spare AAIs into educational establishments from parents, HCPs and teachers?

% of parents and teachers reporting AAIs in schools 93% 83%

How many devices are children prescribed?

Conclusions AAIs are very common in educational establishments Misfiring, forgetting to carry and out of date devices are commons This can place allergic children at risk Spare AAIs would increase availability and help ensure an in-date device is available

Overall summary There is a clear rationale for the introduction of spare AAIs The majority of UK schools have at least one food allergic child The introduction of spare AAIs addresses all current barriers which may prevent the correct use of AAIs in an emergency …and facilitate improved awareness and training Finally, there is overwhelming support from parents, healthcare professional and teachers

The campaign so far Initial meeting with DH Dec 2014 First half of 2015 evidence gathering Evidence presented to DH July 2015 DH present to MHRA July/August 2015 Response and follow up questions and clarifications October 2015 Further follow up questions throughout early 2016 Update meeting with DH March 2016

The campaign so far Further discussions DH and MHRA All Party Group prepare to lobby MHRA agree to table for discussion at future meeting DH ask us to prepare a draft guidance for teachers MHRA meeting September 2016 Decision to begin process to change legislation made public October 2016 Awaiting date for public consultation

Observations Be patient! DH prefer to work with coalitions via one central contact Lobbying needs to be carefully considered Decisions are made only at certain times of the year Clinical input essential As is patient support Good, well planned and evidence based campaigning gets the result

Any questions? mandy@anaphylaxis.org.uk www.anaphylaxis.org.uk @AllergyCampaign